This episode examines histamine and bradykinin as first-response mediators—fast, local signals that change vascular tone, permeability, and sensation almost instantly. We explore why these systems are indispensable for defence yet prone to excess, and how antagonists work not by silencing immunity but by restoring proportion. Seeing histamine and bradyk…

This episode brings together inflammation, fever, pain, and gout as interconnected expressions of the same signalling economy. We explore how prostaglandins and cytokines coordinate protective responses—and how excess or persistence turns protection into pathology. Rather than cataloguing drugs, we focus on where and how interventions act: upstream synt…

This episode examines lipid-derived autacoids as local decision-makers: short-lived signals synthesised on demand from membrane lipids. Prostaglandins, thromboxanes, leukotrienes, and platelet-activating factor do not travel far or last long—but where and when they appear matters enormously. By mapping their synthesis and actions, we make sense of infla…

This episode explores vaccines and immune globulins as anticipatory medicine. Instead of treating disease after damage occurs, these interventions shape immune memory, readiness, and rapid response. We contrast active immunisation with passive protection, examine how antigen design and delivery influence durability, and frame adverse effects as predicta…

This episode examines immunosuppressants and tolerogens as instruments of intentional restraint. When immune activation becomes misdirected—against self, grafts, or chronic inflammation—therapy aims not to erase immunity, but to recalibrate it. We explore how different classes intervene at distinct checkpoints of immune activation, why timing and combin…

This episode introduces immunity and inflammation as tightly linked survival systems rather than isolated pathways. Inflammation is not a mistake; it is an organised response designed to contain threat, recruit help, and initiate repair. Problems arise when these responses are excessive, misdirected, or persist beyond their usefulness. We explore immune…

This episode reframes dyslipidaemia as a risk state rather than a symptomatic disease. Lipids move constantly through the body as energy, structure, and signal; when their transport and clearance become unbalanced, vascular injury accumulates silently over decades. We explore lipid-lowering therapy as preventive pharmacology at its most powerful—interve…

This episode frames coagulation as a dynamic balance—a system designed to seal injury quickly while staying fluid everywhere else. Thrombosis and bleeding represent opposite failures of the same regulatory network. We map the coagulation cascade, platelet activation, and fibrinolysis as interacting processes, then show how anticoagulants, antiplatelet a…

This episode explores pulmonary arterial hypertension (PAH) as a disease of misplaced resistance. The pulmonary circulation is designed for flow, not force; when vascular tone and remodelling raise pressure, the right ventricle is pushed beyond its physiological design. We examine PAH therapies as targeted attempts to reopen pathways, rebalance signalli…

This episode explores antiarrhythmic therapy as an exercise in electrical diplomacy. Cardiac rhythm emerges from finely timed ion fluxes and conduction pathways; disturbance can arise from abnormal automaticity, triggered activity, or re-entry. Rather than memorising drug classes, we build a physiological map of impulse generation and propagation, then …